期刊文献+

发挥中医药特色优势,推动中医可持续发展 被引量:9

Making full use of Traditional Chinese Medicine for hospital's sustainable development
下载PDF
导出
摘要 中医药学的特色和优势在中华民族的历史上曾有着卓越的贡献,在当今人民群众的社会生活中依然有着重要的现实意义。充分发挥中医药特色和优势,要通过继承创新,"六名建设",加强管理,广泛宣传,推动中医可持续发展。 Traditional Chinese Medicine once played an important role in the Chinese history and is still important in modern time.The traditional Chinese medicine should be made full use of for hospital's sustainable development by inheritance and innovation,extensive propaganda,reinforcement in management,and winning the acknowledgement of public.
出处 《安徽卫生职业技术学院学报》 2008年第3期1-3,41,共4页 Journal of Anhui Health Vocational & Technical College
关键词 中医药 特色优势 可持续发展 Traditional Chinese medicine,advantage,sustaiuable development
  • 相关文献

参考文献6

  • 1许金成,王淑斐,凌文革,梁庆祥.心力衰竭患者血浆白细胞介素-12、白细胞介素-18和γ-干扰素水平变化及意义[J].中国综合临床,2005,21(8):673-675. 被引量:7
  • 2Kelly RA, Smith TW. Cytokine and cardiac contraotile functionl. Circulation, 1997,95:778-781
  • 3Dinarello CA. IL-18: A Thl-inducing,proiflammatory cytokine and new member of the IL-1 family [J]. J Allergy Clin Immunol,1999,103(1 Pt 1):11-24
  • 4Mallat Z, Corbaz A, Scoezec A,et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability [J]. Circulation, 2001,104 (14):1598-1603
  • 5Pomerantz B J, Reznikov LL. Inhibition of caspase- 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-113 [J]. Pro Natl Acad Sci USA, 2001, 98(5):2871-2876
  • 6Blankenberg S, Luc G, Ducimentiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men[J].Circulation,2003, 108(20):2453-2459

二级参考文献13

  • 1Yoshimoto T,Takeda K,Tanaka T,et al.IL-12 up-regulates IL-18 receptor expression on T cells,Th1 cells,and B cells:synergism with IL-18 for IFN-gamma production[J].J Immunol,1998,161(7):3 400-3 407.
  • 2Esfandiari E,Mcinnes IB,Lindop G,et al.A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease[J].J Immunol,2001,167(9):5 338-5 347.
  • 3Feldman AM,Combes A,Wagner D,et al.The role of tumor necrosis factor in the pathophysiology of heart failure[J].J Am Coll Cardiol,2000,35(3):537-544.
  • 4Kelly RA,Smith TW.Cytokines and cardiac contractile function[J].Circulation,1997,95(4):778-781.
  • 5Yamaoka-Tojo M,Tojo T,Inomata T,et al.Circulating levels of interleukin 18 reflect etiologies of heart failure:Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8(1):21-27.
  • 6Colucci WS.Molecular and cellular mechanisms of myocardial failure[J].Am J Cardiol,1997,80(11A):15-25.
  • 7Giverta MM,Collucci WS.New targets for heart-failure therapy:endothelin,inflammatory,cytokines,oxidative stress[J].Lancet,1998,352(Suppl 1):34-38.
  • 8Gage JR,Fonarow G,Hamilton M,et al.Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure[J].Neuroimmunomodulation,2004,11(3):173-180.
  • 9Mallat Z,Heymes C,Corbaz A,et al.Evidence for altered interleukin 18(IL-18) pathway in human heart failure[J].FASEB J,2004,18(14):1 752-1 754.
  • 10Neumann D,Del Giudice E,Ciaramella A,et al.Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain[J].J Immunol,2001,166(6):3 757-3 762.

共引文献6

同被引文献61

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部